Literature DB >> 12492180

Esophageal pneumatic dilation for postfundoplication dysphagia: safety, efficacy, and predictors of outcome.

J M Hui1, D R Hunt, D J de Carle, R Williams, I J Cook.   

Abstract

OBJECTIVE: Persistent dysphagia occurs in 5-10% of patients after fundoplication. The cause is obscure in most cases, and the management has not been well established. The aim of this study is to evaluate the clinical outcomes and the predictors of success for esophageal pneumatic dilations in patients with dysphagia after fundoplication.
METHODS: We retrospectively reviewed 14 patients who underwent pneumatic dilation for persistent postfundoplication dysphagia. All patients had esophageal manometry before dilations.
RESULTS: There were nine responders to pneumatic dilations (30-40-mm balloons). The nadir lower esophageal sphincter (LES) relaxation pressure was the only significant predictor for successful dilation and was higher among the responders than nonresponders (median 10 mm Hg vs 5 mm Hg). All six of 14 patients with nadir LES pressure > or = 10 mm Hg had a good response. There was no significant difference in the LES basal pressure between the responders and nonresponders (median 20 mm Hg vs 12 mm Hg). The median distal peristaltic amplitude (74 mm Hg vs 69 mm Hg), percent of failed peristalsis (8% vs 45%), and ramp pressure (19 mm Hg vs 17 mm Hg) did not differ significantly between the responders and nonresponders. No perforations occurred.
CONCLUSIONS: Pneumatic dilation is a reasonably safe and effective treatment for patients with postfundoplication dysphagia. Raised nadir LES relaxation pressure seems to be a useful predictor of successful outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12492180     DOI: 10.1111/j.1572-0241.2002.07115.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Management of esophageal symptoms following fundoplication.

Authors:  Gregory S Sayuk; Ray E Clouse
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

2.  Metabolic changes in the lower esophageal sphincter influencing the result of anti-reflux surgical interventions in chronic gastroesophageal reflux disease.

Authors:  Aron Altorjay; Arpad Juhasz; Viola Kellner; Gellert Sohar; Matyas Fekete; Istvan Sohar
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Post-Nissen Dysphagia and Bloating Syndrome: Outcomes After Conversion to Toupet Fundoplication.

Authors:  Katrin Schwameis; Jörg Zehetner; Kais Rona; Peter Crookes; Nikolai Bildzukewicz; Daniel S Oh; Geoffrey Ro; Katherine Ross; Kulmeet Sandhu; Namir Katkhouda; Jeffrey A Hagen; John C Lipham
Journal:  J Gastrointest Surg       Date:  2016-11-10       Impact factor: 3.452

4.  Postoperative dysphagia is not predictive of long-term failure after laparoscopic antireflux surgery.

Authors:  Konstantinos I Makris; Maria A Cassera; Andrew S Kastenmeier; Christy M Dunst; Lee L Swanström
Journal:  Surg Endosc       Date:  2011-09-10       Impact factor: 4.584

Review 5.  Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics.

Authors:  Dhyanesh A Patel; Rena Yadlapati; Michael F Vaezi
Journal:  Gastroenterology       Date:  2022-02-25       Impact factor: 33.883

6.  UK guidelines on oesophageal dilatation in clinical practice.

Authors:  Sarmed S Sami; Hasan N Haboubi; Yeng Ang; Philip Boger; Pradeep Bhandari; John de Caestecker; Helen Griffiths; Rehan Haidry; Hans-Ulrich Laasch; Praful Patel; Stuart Paterson; Krish Ragunath; Peter Watson; Peter D Siersema; Stephen E Attwood
Journal:  Gut       Date:  2018-02-24       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.